News | The Key Role of Myostatin (MSTN) in Female Fertility
Dr. Liji Thomas published a review in Reproductive Biology and Endocrinology on the role of myostatin (MSTN) in female fertility. MSTN, also known as growth differentiation factor 8 (GDF8), is a protein encoded on chromosome 2. Recent studies indicate that MSTN not only plays an important role in regulating skeletal muscle growth but also has key functions in the female reproductive system, affecting ovarian function, follicular development, ovulation, embryo implantation, and other fertility-related processes.
The Role of MSTN in Female Reproduction
MSTN's functions are not limited to regulating skeletal muscle growth; its role in the female reproductive system has received increasing scientific attention. MSTN affects ovarian function through several mechanisms and regulates steroid synthesis in ovarian granulosa cells, particularly by lowering progesterone concentrations and increasing estradiol synthesis, thereby affecting reproductive hormone balance.
In ovarian granulosa cells, MSTN promotes estradiol synthesis by upregulating aromatase (P450) expression. MSTN also increases follicle-stimulating hormone (FSH) receptor expression, further enhancing the hormone's effects. These actions indicate that MSTN plays a crucial role in regulating sex hormone production and follicular growth.
MSTN also helps regulate granulosa cell proliferation, follicular development, and blood supply to the corpus luteum by upregulating connective tissue growth factor (CTGF), supporting follicular maturation. In addition, MSTN can inhibit the expression of pentraxin 3 (PTX3), which plays an important role in extracellular matrix (ECM) formation and cumulus expansion, thereby affecting ovulation and fertilization.
MSTN and Ovarian Disorders
Abnormal MSTN expression is closely associated with several ovarian disorders. In ovarian hyperstimulation syndrome (OHSS), for example, MSTN may contribute by increasing aromatase and estradiol levels. OHSS is a common and potentially serious adverse effect of fertility treatment, characterized by enlarged ovaries, fluid leakage, and other symptoms.
MSTN expression is also elevated in ovarian granulosa cells and large follicles in polycystic ovary syndrome (PCOS). This suggests that dysregulated MSTN activity may affect follicular development and ovulation in PCOS.
Potential Role of MSTN in Assisted Reproduction
MSTN levels are closely associated with pregnancy rates among patients undergoing in vitro fertilization/intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET). Research indicates that MSTN expression may predict embryo implantation. MSTN may affect this critical process by regulating the growth of uterine smooth muscle cells and endometrial epithelium.
MSTN and Placental and Uterine Physiology
MSTN also affects placental development by regulating cytokines that control trophoblast growth, differentiation, and invasion, all of which are essential for normal embryo implantation. During early pregnancy, MSTN regulates placental function by increasing follistatin-like 3 (FSTL3) levels. Changes in FSTL3 may also be associated with pregnancy complications such as gestational hypertension and fetal growth restriction.
MSTN expression is lower in the mature placenta, but it continues to help regulate placental glucose homeostasis and may offer new directions for treating conditions such as placental insufficiency and gestational diabetes.
Conclusion
Myostatin (MSTN) has multiple roles in female reproductive health, including regulating ovarian hormone synthesis, follicular development, ovarian disorders, and outcomes of assisted reproductive treatment. Although current research has identified key roles for MSTN in several reproductive processes, its specific mechanisms in reproductive health require further investigation. Future research may identify new therapeutic targets for infertility, ovarian disorders, and pregnancy-related complications.
News | The Key Role of Myostatin (MSTN) in Female Fertility
News | The Key Role of Myostatin (MSTN) in Female Fertility
Dr. Liji Thomas published a review in Reproductive Biology and Endocrinology on the role of myostatin (MSTN) in female fertility. MSTN, also known as growth differentiation factor 8 (GDF8), is a protein encoded on chromosome 2. Recent studies indicate that MSTN not only plays an important role in regulating skeletal muscle growth but also has key functions in the female reproductive system, affecting ovarian function, follicular development, ovulation, embryo implantation, and other fertility-related processes.
The Role of MSTN in Female Reproduction
MSTN's functions are not limited to regulating skeletal muscle growth; its role in the female reproductive system has received increasing scientific attention. MSTN affects ovarian function through several mechanisms and regulates steroid synthesis in ovarian granulosa cells, particularly by lowering progesterone concentrations and increasing estradiol synthesis, thereby affecting reproductive hormone balance.
In ovarian granulosa cells, MSTN promotes estradiol synthesis by upregulating aromatase (P450) expression. MSTN also increases follicle-stimulating hormone (FSH) receptor expression, further enhancing the hormone's effects. These actions indicate that MSTN plays a crucial role in regulating sex hormone production and follicular growth.
MSTN also helps regulate granulosa cell proliferation, follicular development, and blood supply to the corpus luteum by upregulating connective tissue growth factor (CTGF), supporting follicular maturation. In addition, MSTN can inhibit the expression of pentraxin 3 (PTX3), which plays an important role in extracellular matrix (ECM) formation and cumulus expansion, thereby affecting ovulation and fertilization.
MSTN and Ovarian Disorders
Abnormal MSTN expression is closely associated with several ovarian disorders. In ovarian hyperstimulation syndrome (OHSS), for example, MSTN may contribute by increasing aromatase and estradiol levels. OHSS is a common and potentially serious adverse effect of fertility treatment, characterized by enlarged ovaries, fluid leakage, and other symptoms.
MSTN expression is also elevated in ovarian granulosa cells and large follicles in polycystic ovary syndrome (PCOS). This suggests that dysregulated MSTN activity may affect follicular development and ovulation in PCOS.
Potential Role of MSTN in Assisted Reproduction
MSTN levels are closely associated with pregnancy rates among patients undergoing in vitro fertilization/intracytoplasmic sperm injection and embryo transfer (IVF/ICSI-ET). Research indicates that MSTN expression may predict embryo implantation. MSTN may affect this critical process by regulating the growth of uterine smooth muscle cells and endometrial epithelium.
MSTN and Placental and Uterine Physiology
MSTN also affects placental development by regulating cytokines that control trophoblast growth, differentiation, and invasion, all of which are essential for normal embryo implantation. During early pregnancy, MSTN regulates placental function by increasing follistatin-like 3 (FSTL3) levels. Changes in FSTL3 may also be associated with pregnancy complications such as gestational hypertension and fetal growth restriction.
MSTN expression is lower in the mature placenta, but it continues to help regulate placental glucose homeostasis and may offer new directions for treating conditions such as placental insufficiency and gestational diabetes.
Conclusion
Myostatin (MSTN) has multiple roles in female reproductive health, including regulating ovarian hormone synthesis, follicular development, ovarian disorders, and outcomes of assisted reproductive treatment. Although current research has identified key roles for MSTN in several reproductive processes, its specific mechanisms in reproductive health require further investigation. Future research may identify new therapeutic targets for infertility, ovarian disorders, and pregnancy-related complications.
Story source:
Collected online